Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
14.59
-0.79 (-5.14%)
At close: Jul 11, 2025, 4:00 PM
14.60
+0.01 (0.07%)
After-hours: Jul 11, 2025, 4:04 PM EDT
Rapport Therapeutics Market Cap
Rapport Therapeutics has a market cap or net worth of $532.87 million as of July 11, 2025. Its market cap has decreased by -35.82% in one year.
Market Cap
532.87M
Enterprise Value
255.33M
1-Year Change
-35.82%
Ranking
Category
Stock Price
14.59
Market Cap Chart
Since the IPO on June 7, 2024, Rapport Therapeutics's market cap has decreased from $601.40M to $532.87M, a decrease of -11.40%. That is a compound annual growth rate of -10.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 532.87M | -17.88% |
| Dec 31, 2024 | 648.87M | 7.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 701.33B |
| Johnson & Johnson | 376.86B |
| AbbVie | 339.43B |
| Novo Nordisk | 316.64B |
| UnitedHealth Group | 272.55B |
| Novartis AG | 243.81B |
| Abbott Laboratories | 229.07B |
| AstraZeneca | 223.49B |